Glioblastoma Multiforme (GBM) is the deadliest and most aggressive form of brain cancer for which there is currently no cure. This often-fatal brain cancer accounts for 45% of all malignant brain tumors and 12,000 cancer diagnoses per year in the United States, in addition to...
[vc_row][vc_column width="1/4"][vc_single_image image="27042" img_size="large" css=""][/vc_column][vc_column width="3/4"][vc_column_text css=""]In what could be a major breakthrough, scientists at the Korea Advanced Institute of Science and Technology (KAIST) in South Korea claim to have identified the cellular origin of glioblastoma, a fast-growing type of central nervous system tumor that...
FOR IMMEDIATE RELEASE: November 8, 2018 CONTACT: Global Coalition for Adaptive Research Rachel Rosenstein-Sisson, Executive Assistant E-mail: rrosenstein.sisson@gcaresearch.org / Phone: 617-299-6471 National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 LEXINGTON, MA & ROCKVILLE, MD - Gary Gordon, M.D., Ph.D., has been named...
This year marks the 13th anniversary of Carmen Rice’s survival from Glioblastoma Multiforme (GBM) – the deadliest brain cancer that is widely regarded as incurable and universally fatal. Carmen’s thirteen-year survival is nothing less than miraculous and last month, we shared her incredible story with...
[vc_row][vc_column][vc_video link="https://youtu.be/jp7v2avE1Ls" el_width="80" align="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]This year marks the 13th anniversary of Carmen Rice’s survival from Glioblastoma Multiforme (GBM) – the deadliest brain cancer that is widely regarded as incurable and universally fatal. GBM kills 91% of patients within three years of diagnosis, and NFCR...
Search NFCR
Popular searches